HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression

le Junk, Damian J., Bryson, Benjamin L., Jackson, Mark W.
Foilsithe 2014

p53 induces distinct epigenetic states at its direct target promoters

le Vrba, Lukas, Junk, Damian J, Novak, Petr, Futscher, Bernard W
Foilsithe 2008

Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells

le Junk, Damian J., Cipriano, Rocky, Stampfer, Martha, Jackson, Mark W.
Foilsithe 2013

STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence

le Bryson, Benjamin L., Junk, Damian J., Cipriano, Rocky, Jackson, Mark W.
Foilsithe in Cell Cycle (2016)

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

le Doherty, Mary R., Smigiel, Jacob M., Junk, Damian J., Jackson, Mark W.
Foilsithe in Cancers (Basel) (2016)

Tumor Microenvironmental Signaling Elicits Epithelial-Mesenchymal Plasticity through Cooperation with Transforming Genetic Events

le Junk, Damian J, Cipriano, Rocky, Bryson, Benjamin L, Gilmore, Hannah L, Jackson, Mark W
Foilsithe 2013

Youth Enjoy Science Program at the Case Comprehensive Cancer Center: Increasing Engagement and Opportunity for Underrepresented Minority Students

le Qua, Kelli, Papp, Klara K., Junk, Damian J., Webb Hooper, Monica, Berger, Nathan A.
Foilsithe in Ethn Dis (2020)

Different Mutant/Wild-Type p53 Combinations Cause a Spectrum of Increased Invasive Potential in Nonmalignant Immortalized Human Mammary Epithelial Cells

le Junk, Damian J, Vrba, Lukas, Watts, George S, Oshiro, Marc M, Martinez, Jesse D, Futscher, Bernard W
Foilsithe 2008

The Acetyltransferase p300/CBP-Associated Factor Is a p53 Target Gene in Breast Tumor Cells

le Watts, George S, Oshiro, Marc M, Junk, Damian J, Wozniak, Ryan J, Watterson, Summer J, Domann, Frederick E, Futscher, Bernard W
Foilsithe 2004

The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer

le Doherty, Mary R., Parvani, Jenny G., Tamagno, Ilaria, Junk, Damian J., Bryson, Benjamin L., Cheon, Hyeon Joo, Stark, George R., Jackson, Mark W.
Foilsithe in Breast Cancer Res (2019)

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer

le Doherty, Mary R., Cheon, HyeonJoo, Junk, Damian J., Vinayak, Shaveta, Varadan, Vinay, Telli, Melinda L., Ford, James M., Stark, George R., Jackson, Mark W.
Foilsithe in Proc Natl Acad Sci U S A (2017)

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage

le Cheon, HyeonJoo, Holvey-Bates, Elise G, Schoggins, John W, Forster, Samuel, Hertzog, Paul, Imanaka, Naoko, Rice, Charles M, Jackson, Mark W, Junk, Damian J, Stark, George R
Foilsithe 2013

Epigenetic silencing of DSC3 is a common event in human breast cancer

le Oshiro, Marc M, Kim, Christina J, Wozniak, Ryan J, Junk, Damian J, Muñoz-Rodríguez, José L, Burr, Jeanne A, Fitzgerald, Matthew, Pawar, Sangita C, Cress, Anne E, Domann, Frederick E, Futscher, Bernard W
Foilsithe 2005

Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance

le Adorno-Cruz, Valery, Kibria, Golam, Liu, Xia, Doherty, Mary, Junk, Damian J., Guan, Dongyin, Hubert, Chris, Venere, Monica, Mulkearns-Hubert, Erin, Sinyuk, Maksim, Alvarado, Alvaro, Caplan, Arnold I., Rich, Jeremy, Gerson, Stanton L., Lathia, Justin, Liu, Huiping
Foilsithe in Cancer Res (2015)